Used in research for the treatment of autoimmune diseases, particularly psoriasis and other inflammatory conditions. It functions as a selective inhibitor of tyrosine kinases involved in immune cell signaling, helping to modulate the overactive immune response. Shows potential in reducing skin inflammation and plaque formation in preclinical models. Investigated for oral bioavailability and targeted action with minimal off-target effects. Currently in experimental stages with focus on safety and efficacy in humans.